Reliv International Inc Revenue Growth Rates (RELV), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Reliv International Inc  (RELV)
 

RELV's Revenue Growth by Quarter and Year

Reliv International Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RELV Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
4th Quarter December -
3rd Quarter September 8.67
2nd Quarter June 8.02
1st Quarter March 10.28
FY 26.97

RELVs Annual Revenue
Reliv International Inc's Revenue in the fiscal year 2019 $ 35.06 millions
Reliv International Inc's Revenue in the fiscal year 2018 $ 36.12 millions
Reliv International Inc's Revenue in the fiscal year 2017 $ 41.79 millions
Reliv International Inc's Revenue in the fiscal year 2016 $ 45.51 millions
Reliv International Inc's Revenue in the fiscal year 2015 $ 51.77 millions




RELV Revenue third quarter 2020 Y/Y Growth Comment
Reliv International Inc reported decrease in Revenue in the third quarter 2020 by -5.26% to $ 8.67 millions, from the same quarter in 2019.
Despite modest results in the third quarter 2020, contraction in Reliv International Inc's Revenue appears to be smaller than Company's recent average decline.

Looking into third quarter 2020 results within Major Pharmaceutical Preparations industry 169 other companies have achieved higher Revenue growth. While Reliv International Inc' s Revenue decline of -5.26% ranks overall at the positon no. 2640 in the third quarter 2020.


RELV Revenue ( Y/Y Growth %) 2020
 2019 2018 2017
4th Quarter December - -12.45 % -6.24 % -6.58 %
3rd Quarter September -5.26 % 9.71 % -8.05 % -15.94 %
2nd Quarter June -2.91 % -2.36 % -15.48 % -9.41 %
1st Quarter March 8.32 % -5.1 % -21.75 % -1.99 %
FY   - -2.93 % -13.59 % -

Financial Statements
Reliv International Inc's third quarter 2020 Revenue $ 8.67 millions RELV's Income Statement
Reliv International Inc's third quarter 2019 Revenue $ 9.15 millions Quarterly RELV's Income Statement


RELV Revenue (Quarter on Quarter Growth %)

 2020
 2019 2018 2017
4th Quarter December - -10.82 % 11.75 % 9.59 %
3rd Quarter September 8.08 % 10.77 % -1.42 % -9.39 %
2nd Quarter June -21.98 % -12.96 % -15.4 % -21.67 %
1st Quarter March 25.98 % 1.82 % 0.6 % 20.11 %
FY (Year on Year)   - -2.93 % -13.59 % -


Back to RELV Growth rate Comparisons >> Back to RELV Growth rate Comparisons >>


Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #170
Healthcare Sector #452
Overall #2640

Revenue Y/Y Growth Statistics
High Average Low
9.74 % -7.71 % -23.29 %
(Dec 31 2016)   (Dec 31 2015)
Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #170
Healthcare Sector #452
Overall #2640
Revenue Y/Y Growth Statistics
High Average Low
9.74 % -7.71 % -23.29 %
(Dec 31 2016)   (Dec 31 2015)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Reliv International Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
58.97 % -1.44 % -32.75 %
(Mar 31 2016)  


RELV's III. Quarter Q/Q Revenue Comment
Reliv International Inc achieved in the III. Quarter 2020 above company average sequential Revenue increase of 8.08%, to $ 8.67 millions, from $8.02 millions in the second quarter.

Within Major Pharmaceutical Preparations industry 132 other companies have achieved higher Revenue quarter on quarter growth. While Reliv International Inc's Revenue growth quarter on quarter, overall rank is 2158.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #133
Healthcare Sector #387
Overall #2158
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #133
Healthcare Sector #387
Overall #2158
Revenue Q/Q Growth Statistics
High Average Low
58.97 % -1.44 % -32.75 %
(Mar 31 2016)  


RELV's III. Quarter Q/Q Revenue Comment
Reliv International Inc achieved in the III. Quarter 2020 above company average sequential Revenue increase of 8.08%, to $ 8.67 millions, from $8.02 millions in the second quarter.

Within Major Pharmaceutical Preparations industry 132 other companies have achieved higher Revenue quarter on quarter growth. While Reliv International Inc's Revenue growth quarter on quarter, overall rank is 2158.


Reliv International Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2020)		 12 Months Ending
(Jun 30 2020)		 12 Months Ending
(Mar 31 2020)		 12 Months Ending
(Dec 31 2019)		 12 Months Ending
(Sep 30 2019)
Cumulative Revenue 12 Months Ending $ 35.13 $ 35.61 $ 35.85 $ 35.06 $ 36.21
Y / Y Revenue Growth (TTM) -2.99 % 0.59 % 0.69 % -2.94 % -1.43 %
Year on Year Revenue Growth Overall Ranking # 1998 # 1537 # 1597 # 2404 # 1911
Seqeuential Revenue Change (TTM) -1.35 % -0.67 % 2.26 % -3.19 % 2.29 %
Seq. Revenue Growth (TTM) Overall Ranking # 1485 # 1404 # 2375 # 2772 # 2366


Cumulative Revenue growth Comment
For the 12 months ended Sep 30 2020 Reliv International Inc reported a decrease in Revenue by -2.99% year on year, to $35 millions, compare to the 0.59% growth at Jun 30 2020.

In the Healthcare sector 346 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1537 to 1998.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 106
Healthcare Sector # 347
Overall # 1998

Revenue TTM Y/Y Growth Statistics
High Average Low
0.69 %
 -8.29 %
-15.92 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 106
Sector # 249
S&P 500 # 1485
Cumulative Revenue growth Comment
For the 12 months ended Sep 30 2020 Reliv International Inc reported a decrease in Revenue by -2.99% year on year, to $35 millions, compare to the 0.59% growth at Jun 30 2020.

In the Healthcare sector 346 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1537 to 1998.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 106
Healthcare Sector # 347
Overall # 1998

Revenue TTM Y/Y Growth Statistics
High Average Low
0.69 %
-8.29 %
-15.92 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 106
Sector # 249
S&P 500 # 1485




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RELV's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2020
Ensign Group Inc-0.21%$ -0.208 millions
Crh Medical Corporation-0.21%$ -0.215 millions
Radnet Inc -0.24%$ -0.237 millions
Tenet Healthcare Corp-0.24%$ -0.241 millions
Prestige Consumer Healthcare Inc -0.27%$ -0.272 millions
Establishment Labs Holdings Inc -0.42%$ -0.420 millions
Cocrystal Pharma Inc -0.61%$ -0.610 millions
American Renal Associates Holdings Inc -0.82%$ -0.823 millions
Rockwell Medical inc -0.83%$ -0.826 millions
Tactile Systems Technology Inc -1.05%$ -1.048 millions
Icon Plc-1.23%$ -1.226 millions
American Bio Medica Corporation-1.34%$ -1.341 millions
Transmedics Group Inc -1.58%$ -1.582 millions
Boston Scientific Corporation-1.77%$ -1.773 millions
Bruker Corporation-1.86%$ -1.861 millions
Orthofix Medical Inc -2.21%$ -2.215 millions
Encision Inc -2.29%$ -2.288 millions
Integra Lifesciences Holdings Corp-2.34%$ -2.338 millions
Neurometrix Inc -2.48%$ -2.480 millions
Lifevantage Corp-2.49%$ -2.492 millions
Macrogenics Inc -2.60%$ -2.604 millions
Surgalign Holdings Inc -2.70%$ -2.704 millions
Alimera Sciences Inc-2.93%$ -2.934 millions
Fortress Biotech Inc -3.04%$ -3.039 millions
Teleflex Incorporated-3.09%$ -3.088 millions
Adm Tronics Unlimited Inc -3.10%$ -3.105 millions
Bausch Health Companies Inc -3.21%$ -3.214 millions
Atricure Inc -3.28%$ -3.280 millions
Aspira Women s Health inc -3.58%$ -3.580 millions
Electromed Inc -3.59%$ -3.593 millions


About Reliv International Inc Revenue Growth Rates (RELV), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.